Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21159366 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: gemcitabine hydrochloride

Indicates status has not been verified in more than two years